Lieberman E B, Bashore T M, Hermiller J B, Wilson J S, Pieper K S, Keeler G P, Pierce C H, Kisslo K B, Harrison J K, Davidson C J
Duke University Medical Center, Division of Cardiology, Durham, North Carolina 27710, USA.
J Am Coll Cardiol. 1995 Nov 15;26(6):1522-8. doi: 10.1016/0735-1097(95)00363-0.
This study sought to determine the long-term outcome of adult patients undergoing percutaneous balloon aortic valvuloplasty.
Percutaneous balloon aortic valvuloplasty has been offered as an alternative to aortic valve replacement for selected patients with valvular aortic stenosis. Although balloon aortic valvuloplasty produces an immediate reduction in the transvalvular aortic gradient, a high incidence of restenosis frequently leads to recurrent symptoms. Therefore, it is unclear whether balloon aortic valvuloplasty impacts on the long-term outcome of these patients.
Clinical, hemodynamic and echocardiographic data were collected at baseline in 165 patients undergoing balloon aortic valvuloplasty and examined for their ability to predict long-term outcome.
The median duration follow-up was 3.9 years (range 1 to 6). Ninety-nine percent follow-up was achieved. During this 6-year period, 152 patients (93%) died or underwent aortic valve replacement, and 99 (60%) died of cardiac-related causes. The probability of event-free survival (freedom from death, aortic valve replacement or repeat balloon aortic valvuloplasty) 1, 2 and 3 years after valvuloplasty was 40%, 19% and 6%, respectively. In contrast, the probability of survival 3 years after balloon aortic valvuloplasty in a subset of 42 patients who underwent subsequent aortic valve replacement was 84%. Survival after aortic valvuloplasty was poor regardless of the presenting symptom, but patients with New York Heart Association functional class IV congestive heart failure had events earliest. Univariable predictors of decreased event-free survival were younger age, advanced congestive heart failure symptoms, lower ejection fraction, elevated left ventricular end-diastolic pressure, presence of coronary artery disease and increased left ventricular internal diastolic diameter. Stepwise multivariable logistic regression analysis found that only younger age and a lower left ventricular ejection fraction contributed independent adverse prognostic information (chi-square 14.89, p = 0.0006).
Long-term event-free and actuarial survival after balloon aortic valvuloplasty is dismal and resembles the natural history of untreated aortic stenosis. Aortic valve replacement may be performed in selected subjects with good results. However, the prognosis for the remainder of patients who are not candidates for aortic valve replacement is particularly poor.
本研究旨在确定接受经皮球囊主动脉瓣成形术的成年患者的长期预后。
对于选定的主动脉瓣狭窄患者,经皮球囊主动脉瓣成形术已成为主动脉瓣置换术的替代方法。尽管球囊主动脉瓣成形术可使跨瓣主动脉压差立即降低,但再狭窄的高发生率常导致症状复发。因此,球囊主动脉瓣成形术是否会影响这些患者的长期预后尚不清楚。
收集了165例接受球囊主动脉瓣成形术患者的基线临床、血流动力学和超声心动图数据,并检查其预测长期预后的能力。
中位随访时间为3.9年(范围1至6年)。随访率达到99%。在这6年期间,152例患者(93%)死亡或接受了主动脉瓣置换术,99例(60%)死于心脏相关原因。瓣膜成形术后1年、2年和3年无事件生存(免于死亡、主动脉瓣置换或再次球囊主动脉瓣成形术)的概率分别为40%、19%和6%。相比之下,在随后接受主动脉瓣置换术的42例患者亚组中,球囊主动脉瓣成形术后3年的生存率为84%。无论初始症状如何,主动脉瓣成形术后的生存率都很低,但纽约心脏协会心功能IV级充血性心力衰竭患者最早出现事件。无事件生存降低的单变量预测因素包括年龄较小、充血性心力衰竭症状严重、射血分数较低、左心室舒张末期压力升高、存在冠状动脉疾病以及左心室内径增加。逐步多变量逻辑回归分析发现,只有年龄较小和左心室射血分数较低提供了独立的不良预后信息(卡方值14.89,p = 0.0006)。
球囊主动脉瓣成形术后的长期无事件生存和实际生存率很差,类似于未经治疗的主动脉狭窄的自然病程。对于选定的患者,进行主动脉瓣置换术可能会取得良好效果。然而,其余不适合进行主动脉瓣置换术的患者预后特别差。